Market Overview

Benzinga's Daily Biotech Pulse: Transenterix Rises, Mylan Earnings, Deutsche Bank Conference Underway

Benzinga's Daily Biotech Pulse: Transenterix Rises, Mylan Earnings, Deutsche Bank Conference Underway
Related IBB
The Daily Biotech Pulse: No Anxiety For Biohaven, Strongbridge's About-Face, Bristol-Myers Squibb's FDA Wait
The Daily Biotech Pulse: Vertex Awaits FDA Verdict, Strongbridge Falls On Offering, ReShape's Woes Continue
Related MYL
Teva Wins FDA Approval For Generic Epinephrine
Benzinga's Top Upgrades, Downgrades For August 13, 2018
White House proposing cuts in opioid production (Seeking Alpha)

Here's a roundup of top developments in the biotech space over the last 24 hours.

Scaling the Peaks

(Stocks hitting 52-week highs on May 8)

  • CONMED Corporation (NASDAQ: CNMD)
  • Enanta Pharmaceuticals Inc (NASDAQ: ENTA)
  • Helius Medical Technologies Inc (NASDAQ: HSDT)
  • SurModics, Inc. (NASDAQ: SRDX)

Down In The Dumps

(Stocks hitting 52-week lows on May 8)

  • Acasti Pharma Inc (NASDAQ: ACST)
  • Agenus Inc (NASDAQ: AGEN) (has been falling since it reported Q1 results on Monday)
  • Alimera Sciences Inc (NASDAQ: ALIM)
  • Aralez Pharmaceuticals Inc (NASDAQ: ARLZ) (reported Q1 results Tuesday and announced plans to discontinue U.S. commercial business)
  • Celgene Corporation (NASDAQ: CELG)
  • Regeneron Pharmaceuticals Inc (NASDAQ: REGN)
  • RXi Pharmaceuticals Corp (NASDAQ: RXII)
  • VBI Vaccines Inc (NASDAQ: VBIV)

Medical/Healthcare/Biotech Conferences

  • 2018 Disruptive Growth and Healthcare Conference – May 8-9, in New York City
  • Deutsche Bank 43rd Annual Health Care Conference – May 8-9, at the InterContinental Boston Hotel

See Also: Attention Biotech Investors: Mark Your Calendar For These May PDUFA Action Dates

Stocks In Focus

Opko Posts Better-than-expected results

Opko Health Inc. (NASDAQ: OPK) reported a narrower-than-expected Q1 loss of 8 cents per share on above-consensus revenues of $254.9 million.

The stock rallied 6.21 percent to $3.42 in after-hours trading.

Penumbra's Beat-And-Raise Quarter

Penumbra Inc (NYSE: PEN) swung to a profit in Q1 and reported above-consensus revenues. The company also raised FY18 revenue guidance.

The stock rallied 5.96 percent to $144 after hours.

Synthetic Biologic Posts Narrower-Than-Expected Loss

Synthetic Biologics Inc (NYSE: SYN) reported a loss of 2 cents per share for its Q1, narrower than the loss of 5 cents expected.

The stock jumped 11.28 percent to $0.2773 in after-hours trading.

OpGen Q1 Beats Estimates

OpGen Inc (NASDAQ: OPGN) reported a narrower-than-expected loss and above-consensus revenues for its Q1.

The stock gained 3.68 percent to $1.97 in after-hours trading.

Transenterix Gains On Q1 Beat

Transenterix Inc (NYSE: TRXC) shares were up 12 percent Wednesday morning in reaction to its Q1 results that showed break-even bottom-line results and revenues of $4.8 million. Analysts, on average, estimated a loss of 7 cents per share on revenues of $3.84 million.

On The Radar

The following companies report earnings on Wednesday:

  • Mylan NV (NASDAQ: MYL) Q1 EPS $0.96 Misses $0.98 Estimate, Sales $2.68B Miss $2.75B Estimate
  • Endocyte, Inc. (NASDAQ: ECYT)
  • FibroGen Inc (NASDAQ: FGEN)
  • Jounce Therapeutics Inc (NASDAQ: JNCE) Q1 EPS $(0.40) Misses $(0.31) Estimate, Sales $11.19M Miss $15.64M Estimate
  • Neos Therapeutics Inc (NASDAQ: NEOS) Q1 EPS $(0.50) Misses $(0.48) Estimate, Sales $10.72M Beat $9.79M Estimate
  • AcelRx Pharmaceuticals Inc (NASDAQ: ACRX)
  • Adaptimmune Therapeutics PLC – ADR (NASDAQ: ADAP) Q3 EPS $(0.04) Beats $(0.24) Estimate, Sales $8.19M Miss $9.1M Estimate
  • Arcadia Biosciences Inc (NASDAQ: RKDA)
  • Array Biopharma Inc (NASDAQ: ARRY)
  • Audentes Therapeutics Inc (NASDAQ: BOLD)
  • Collegium Pharmaceutical Inc (NASDAQ: COLL)
  • Glaukos Corp (NYSE: GKOS)
  • Horizon Pharma PLC (NASDAQ: HZNP) Q1 EPS $0.03 Misses $0.07 Estimate, Sales $223.881M Miss $234.17M Estimate
  • Inovio Pharmaceuticals Inc (NASDAQ: INO)
  • Portola Pharmaceuticals Inc (NASDAQ: PTLA)
  • PTC Therapeutics, Inc. (NASDAQ: PTCT)
  • Puma Biotechnology Inc (NASDAQ: PBYI)
  • Viking Therapeutics Inc (NASDAQ: VKTX)
  • Ophthotech Corp (NASDAQ: OPHT) Q1 EPS $(0.36) Beats $(0.40) Estimate
  • Novavax, Inc. (NASDAQ: NVAX)

Posted-In: Biotech Earnings News Guidance FDA Top Stories Pre-Market Outlook Trading Ideas Best of Benzinga


Related Articles (ACRX + ACST)

View Comments and Join the Discussion!

These Benzinga Global Fintech Award Finalists Are Pioneering Consumer Engagement

A Peek Into The Markets: US Stock Futures Signal Higher Start On Wall Street